Setting up econometric ARIMA methodology to elucidate European Union nosocomial antimicrobial resistance rate trend evolution based on largest EU database

  14 September 2019

Econometric ARIMA model statistically proved slowdowns and reversions in increase trend of nosocomial E. coli and K. pneumoniae resistance to 3GC and FQ, as well as in resistance of P. aeruginosa resistance to 3GC. P. aeruginosa resistance to FQ shows a descending slope. These brakes and decreased trends proved constitute noteworthy milestones in tackling AMR in Europe.

Author(s): Rafael Ortega-Huedo, Marina Cuesta, Andreas Hoefer, Bruno Gonzalez-Zorn
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!